[go: up one dir, main page]

Terfenadine

"Terfenadine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.


expand / collapse Publications
This graph shows the total number of publications written about "Terfenadine" by people in this website by year, and whether "Terfenadine" was a major or minor topic of these publications.
Below are the most recent publications written about "Terfenadine" by people in Profiles.
  1. Fexofenadine Plasma Concentrations to Estimate Systemic Exposure in Healthy Adults Using a Limited Sampling Strategy with a Population Pharmacokinetic Approach. Ther Drug Monit. 2023 08 01; 45(4):539-545.
    View in: PubMed
  2. Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives. Proc Natl Acad Sci U S A. 2020 07 07; 117(27):16009-16018.
    View in: PubMed
  3. Cosmetic tattoo pigment reaction. Dermatol Online J. 2016 Jul 15; 22(7).
    View in: PubMed
  4. In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome. J Mol Cell Cardiol. 2014 Jul; 72:126-37.
    View in: PubMed
  5. Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters? J Clin Psychopharmacol. 2012 Feb; 32(1):110-3.
    View in: PubMed
  6. Pharmacophore modeling for hERG channel facilitation. Biochem Biophys Res Commun. 2012 Feb 03; 418(1):161-6.
    View in: PubMed
  7. Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation. Clin Pharmacokinet. 2010 Apr; 49(4):223-37.
    View in: PubMed
  8. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermographism: a pilot study. J Am Acad Dermatol. 2008 Nov; 59(5):752-7.
    View in: PubMed
  9. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine. J Clin Pharmacol. 2008 Aug; 48(8):957-65.
    View in: PubMed
  10. Lack of action potential-prolonging effect of terfenadine on rabbit myocardial tissue preparations. Biol Pharm Bull. 2004 Jan; 27(1):131-5.
    View in: PubMed